Robot maker Genesis AI raises $500 million at a $3.5 billion valuation. It has not named a paying customer
Genesis AI, a two-year-old maker of factory robots, has raised $500 million at a $3.5 billion valuation. It has not named a single paying customer.
The round, announced Tuesday, is a Series A, usually a company's first major institutional raise. Premji Invest, Khosla Ventures and Eclipse led it.
For investors, the deal is a bet that robots can learn to use their hands the way people do. That skill, called dexterous manipulation, is widely seen as a major hurdle between today's lab demos and robots that do paid work on a factory floor.
Who is paying, and how much
The investor list reaches well beyond venture firms. Chipmakers Nvidia and AMD's venture arm joined, as did Zoom, Samsung Next, Ericsson and France's state investment bank, Bpifrance, according to the company's announcement and Crunchbase News.
Accounts advised by T. Rowe Price and Durable Capital Partners also took part. Firms like these more often invest in public stocks or late-stage private companies.
Individual backers include former Google chief Eric Schmidt, former Yahoo chief Jerry Yang and Zoom chief Eric Yuan. Former Tesla finance chief Zach Kirkhorn is also listed.
Genesis has now raised about $605 million since its 2024 founding, including a $105 million seed round in July 2025. It is based in Paris with an office in San Carlos, California, and has close to 100 employees, Crunchbase reported.
The deal completes talks first reported in July. Reports then, citing Bloomberg, said Genesis was seeking about $500 million at roughly $3 billion before the new cash. That works out to about $3.5 billion including the new money, in line with the final terms.
What the money buys, and what is still unproven
Genesis builds the whole system itself: the robot, the AI software that controls it, and much of the data used to train that software. Its first robot, Eno, has a wheeled base and two arms, with no head or face, Forbes reported.
To collect training data, the company pays more than 100 workers worldwide to wear sensor-laden gloves and head cameras while they do tasks, TechCrunch reported. The robots wear the same gloves, and their hands are built to human proportions. Genesis also trains its software in computer simulations.
The company says the new money will go to more training data and computing power, building more robots, deploying them with customers, and hiring. It plans to start in manufacturing, logistics and laboratories, then move into hospitality and healthcare.
The commercial evidence so far is thin. Genesis has built 30 to 40 Eno robots and is running pilots with a handful of customers it would not name, according to TechCrunch. Its announcement names no customers and gives no revenue, pricing or deployment figures.
Its most visible partner is LG CNS, the systems arm of South Korea's LG Group. A June agreement covers testing Genesis robots at LG sites and LG CNS clients in the US, with no disclosed financial terms. Crunchbase reported that Genesis is considering charging customers for the robot and its software as a single service.
Hardware is a known weak spot. The robot's hands last only a few weeks of regular work before they need replacing, TechCrunch reported. Chief executive Zhou Xian told TechCrunch that hardware, including mechanical design and supply chains, is the main constraint.
A TechCrunch reporter watched a packing demo, run on off-the-shelf robot arms rather than Eno, in which the robot fumbled a box and struggled to peel a label. The reporter was not allowed to test the setup independently. Forbes, which saw Eno in June, reported a lift capacity of roughly 3 to 5 kilograms per arm and four to six hours of battery life, both still being improved.
Why the valuation is a wager on execution
Xian argues that the science is largely solved and the rest is engineering. "We have all the recipes. It's just about execution," he told TechCrunch. That is a company claim, not something outside testing has confirmed.
Others are more cautious. Tyler Habowski, co-founder of robot-hand maker Kyber Labs, told Forbes: "There are literally zero robot hands deployed right now doing routine work."
The field is also crowded. Forbes's robotics writer says he tracks about 600 humanoid robots from more than 400 manufacturers, including Tesla, Figure and Agility. Genesis is betting that better hands, not human-like looks, will set it apart.
For buyers, the near-term question is cost and reliability: hands that wear out in weeks could make a robot expensive to keep running. Genesis has picked a contract manufacturer to start mass production in the US next year, TechCrunch reported.
For investors, with no revenue disclosed, the $3.5 billion price rests on technology and team rather than sales. The next proof points to watch are named customers, how many robots are working at their sites, and how long the hands last on a real shift.